Short-read Sequencing Market Size, Share, Growth Analysis, By Product(Instruments, Consumables), By Workflow(Pre-Sequencing, Sequencing), By Application(Whole Genome Sequencing, Whole Exome Sequencing), By End-Use(Academic & Research Institutes, Hospitals & Clinics), By Regional(North America, Europe) - Industry Forecast 2024-2031

Short-read Sequencing Market Competitive Landscape

To understand the competitive landscape, we are analyzing key Short-read Sequencing Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Short-read Sequencing Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies
• Psomagen
• Azenta US, Inc. (GENEWIZ)
• PerkinElmer, Inc.
• ProPhase Labs, Inc. (Nebula Genomics)